Another report had suggested that treatment of neural cells with metformin, an AMPK activator, resulted in their proliferation in a TAp73-dependent manner.26 These reports together raise the possibility that AMPK activity may regulate p73 to support tumour growth in appropriate cellular settings. Here, PRKAA1 is linked to neoplasm.